+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Steerable Sheaths Market Size, Share & Trends Analysis Report By Type (Single-Use Steerable Sheaths and Reprocessed Steerable Sheaths), By Application, By End-use, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • May 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5976213
The Latin America, Middle East and Africa Steerable Sheaths Market would witness market growth of 8.6% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Steerable Sheaths Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $23.7 million by 2031. The Argentina market is registering a CAGR of 9.8% during (2024 - 2031). Additionally, The UAE market would showcase a CAGR of 8.2% during (2024 - 2031).



Clinical studies demonstrating favourable outcomes, reduced procedural times, and lower complication rates associated with steerable sheath-guided interventions have contributed to clinician confidence and acceptance of these devices.

Additionally, the expanding indications for minimally invasive procedures and the increasing prevalence of complex cardiovascular, neurovascular, and structural heart diseases have created a growing market opportunity for steerable sheaths.

The UAE has one of the highest rates of diabetes and obesity in the world. Both conditions are closely linked to the development of cardiovascular issues such as hypertension, atherosclerosis, and coronary artery disease. As the prevalence of CVD grows in the UAE, there is likely a corresponding increase in the demand for advanced cardiovascular interventions, including steerable sheaths, to meet the healthcare needs of the population.

Based on Type, the market is segmented into Single-Use Steerable Sheaths and Reprocessed Steerable Sheaths. Based on Application, the market is segmented into Electrophysiology (EP) Procedures, Interventional Cardiology Procedures, Peripheral Vascular Procedures, and Others. Based on End-use, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Medtronic PLC
  • Stryker Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Teleflex Incorporated
  • Integer Holdings Corporation
  • Merit Medical Systems, Inc.
  • AngioDynamics, Inc.
  • Johnson & Johnson
  • Obex Medical

Market Report Segmentation

By Type
  • Single-Use Steerable Sheaths
  • Reprocessed Steerable Sheaths
By Application
  • Electrophysiology (EP) Procedures
  • Interventional Cardiology Procedures
  • Peripheral Vascular Procedures
  • Others
By End-use
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Steerable Sheaths Market, by Type
1.4.2 LAMEA Steerable Sheaths Market, by Application
1.4.3 LAMEA Steerable Sheaths Market, by End-use
1.4.4 LAMEA Steerable Sheaths Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Steerable Sheaths Market by Type
4.1 LAMEA Single-Use Steerable Sheaths Market by Country
4.2 LAMEA Reprocessed Steerable Sheaths Market by Country
Chapter 5. LAMEA Steerable Sheaths Market by Application
5.1 LAMEA Electrophysiology (EP) Procedures Market by Country
5.2 LAMEA Interventional Cardiology Procedures Market by Country
5.3 LAMEA Peripheral Vascular Procedures Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Steerable Sheaths Market by End-use
6.1 LAMEA Hospitals & Clinics Market by Country
6.2 LAMEA Ambulatory Surgical Centers Market by Country
Chapter 7. LAMEA Steerable Sheaths Market by Country
7.1 Brazil Steerable Sheaths Market
7.1.1 Brazil Steerable Sheaths Market by Type
7.1.2 Brazil Steerable Sheaths Market by Application
7.1.3 Brazil Steerable Sheaths Market by End-use
7.2 Argentina Steerable Sheaths Market
7.2.1 Argentina Steerable Sheaths Market by Type
7.2.2 Argentina Steerable Sheaths Market by Application
7.2.3 Argentina Steerable Sheaths Market by End-use
7.3 UAE Steerable Sheaths Market
7.3.1 UAE Steerable Sheaths Market by Type
7.3.2 UAE Steerable Sheaths Market by Application
7.3.3 UAE Steerable Sheaths Market by End-use
7.4 Saudi Arabia Steerable Sheaths Market
7.4.1 Saudi Arabia Steerable Sheaths Market by Type
7.4.2 Saudi Arabia Steerable Sheaths Market by Application
7.4.3 Saudi Arabia Steerable Sheaths Market by End-use
7.5 South Africa Steerable Sheaths Market
7.5.1 South Africa Steerable Sheaths Market by Type
7.5.2 South Africa Steerable Sheaths Market by Application
7.5.3 South Africa Steerable Sheaths Market by End-use
7.6 Nigeria Steerable Sheaths Market
7.6.1 Nigeria Steerable Sheaths Market by Type
7.6.2 Nigeria Steerable Sheaths Market by Application
7.6.3 Nigeria Steerable Sheaths Market by End-use
7.7 Rest of LAMEA Steerable Sheaths Market
7.7.1 Rest of LAMEA Steerable Sheaths Market by Type
7.7.2 Rest of LAMEA Steerable Sheaths Market by Application
7.7.3 Rest of LAMEA Steerable Sheaths Market by End-use
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Boston Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Abbott Laboratories
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Stryker Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Teleflex Incorporated
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Integer Holdings Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Merit Medical Systems, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 AngioDynamics, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Johnson & Johnson
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental & Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. Obex Medical (Bunzl Plc)
8.10.1 Company Overview
8.10.2 SWOT Analysis

Companies Mentioned

  • Medtronic PLC
  • Stryker Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Teleflex Incorporated
  • Integer Holdings Corporation
  • Merit Medical Systems, Inc.
  • AngioDynamics, Inc.
  • Johnson & Johnson
  • Obex Medical

Methodology

Loading
LOADING...